Radiomics and radiogenomics of primary liver cancers

키워드

참고문헌 (58)

1. Hricak H, "Oncologic imaging : a guiding hand of personalized cancer care", Radiology, 259, pp.633~640 (2011)
2. Sharma B, "Imaging in oncology--over a century of advances", Nat Rev Clin Oncol, 9, pp.728~737 (2012)
3. Tirkes T, "Response criteria in oncologic imaging : review of traditional and new criteria", Radiographics, 33, pp.1323~1341 (2013)
4. Elsayes KM, "2017 version of LI-RADS for CT and MR imaging : an update", Radiographics, 37, pp.1994~2017 (2017)
5. An C, "Liver imaging reporting and data system(LI-RADS)version 2014 : understanding and application of the diagnostic algorithm", Clin Mol Hepatol, 22, pp.296~307 (2016)
6. "GLOBOCAN 2012:Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012"[URL]
7. Lin DC, "Genomic and epigenomic heterogeneity of hepatocellular carcinoma", Cancer Res, 77, pp.2255~2265 (2017)
8. Lu LC, "Tumor heterogeneity in hepatocellular carcinoma : facing the challenges", Liver Cancer, 5, pp.128~138 (2016)
9. Bruix J, "Hepatocellular carcinoma : clinical frontiers and perspectives", Gut, 63, pp.844~855 (2014)
10. Segal E, "Decoding global gene expression programs in liver cancer by noninvasive imaging", Nat Biotechnol, 25, pp.675~680 (2007)
11. Banerjee S, "A computed tomography radiogenomic biomarker predicts microvascular invasion and clinical outcomes in hepatocellular carcinoma", Hepatology, 62, pp.792~800 (2015)
12. Sadot E, "Cholangiocarcinoma : correlation between molecular profiling and imaging phenotypes", PLoS One, 10, pp.e0132953~ (2015)
13. Davenport MS, "Repeatability of diagnostic features and scoring systems for hepatocellular carcinoma by using MR imaging", Radiology, 272, pp.132~142 (2014)
14. Lee G, "Radiomics and imaging genomics in precision medicine", Precis Future Med, 1, pp.10~31 (2017)
15. Bai HX, "Imaging genomics in cancer research : limitations and promises", Br J Radiol, 89, pp.20151030~ (2016)
16. Pinker K, "Background, current role, and potential applications of radiogenomics", J Magn Reson Imaging, 47, pp.604~620 (2018)
17. Gilles RJ, "Radiomics : images are more than pictures, they are data", Radiology, 278, pp.563~577 (2016)
18. Ganeshan B, "Quantifying tumour heterogeneity with CT", Cancer Imaging, 13, pp.140~149 (2013)
19. Lubner MG, "CT texture analysis : definitions, applications, biologic correlates, and challenges", Radiographics, 37, pp.1483~1503 (2017)
20. 이명은, "Quality of Radiomic Features in Glioblastoma Multiforme: Impact of Semi-Automated Tumor Segmentation Software", Korean Journal of Radiology, 18(3), pp.498~509 (2017), 대한영상의학회[DOI]
21. Nakashima O, "Pathomorphologic characteristics of small hepatocellular carcinoma : a special reference to small hepatocellular carcinoma with indistinct margins", Hepatology, 22, pp.101~105 (1995)
22. International Consensus Group for Hepatocellular Neoplasia, "Pathologic diagnosis of early hepatocellular carcinoma : a report of the international consensus group for hepatocellular neoplasia", Hepatology, 49, pp.658~664 (2009)
23. Choi JY, "CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects", Radiology, 272, pp.635~654 (2014)
24. Lee JS, "A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells", Nat Med, 12, pp.410~416 (2006)
25. Hoshida Y, "Gene expression in fixed tissues and outcome in hepatocellular carcinoma", N Eng J Med, 359, pp.1995~2004 (2008)
26. Hoshida Y, "Molecular classification and novel targets in hepatocellular carcinoma : recent advancements", Semin Liver Dis, 30, pp.35~51 (2010)
27. Martins-Filho SN, "Histological grading of hepatocellular carcinoma-a systematic review of literature", Front Med(Lausanne), 4, pp.193~ (2017)
28. Berretta M, "Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma : clinical and prognostic implications", Oncotarget, 8, pp.14192~14220 (2017)
29. Mazzaferro V, "Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria : a retrospective, exploratory analysis", Lancet Oncol, 10, pp.35~43 (2009)
30. Maetzel D, "Nuclear signaling by tumour-associated antigen EpCAM", Nat Cell Biol, 11, pp.162~171 (2009)
31. van Zijl F, "Epithelial-mesenchymal transition in hepatocellular carcinoma", Future Oncol, 5, pp.1169~1179 (2009)
32. Villanueva A, "New strategies in hepatocellular carcinoma : genomic prognostic markers", Clin Cancer Res, 16, pp.4688~4694 (2010)
33. Villanueva A, "Combining clinical, pathology, and gene expression data to predict recurrence of hepatocellular carcinoma", Gastroenterology, 140, pp.1501~1512 (2011)
34. Chang YT, "Clinicopathological and prognostic significances of EGFR, KRAS and BRAF mutations in biliary tract carcinomas in Taiwan", J Gastroenterol Hepatol, 29, pp.1119~1125 (2014)
35. Yoshikawa D, "Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma", Br J Cancer, 98, pp.418~425 (2008)
36. Mertens JC, "Targeting cholangiocarcinoma", Biochim Biophys Acta, 1864(4 Pt B), pp.1454~1460 (2018)
37. Graham RP, "Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma", Hum Pathol, 45, pp.1630~1638 (2014)
38. Thelen A, "Tumor-associated angiogenesis and lymphangiogenesis correlate with progression of intrahepatic cholangiocarcinoma", Am J Gastroenterol, 105, pp.1123~1132 (2010)
39. Nitta T, "Prognostic significance of epithelial-mesenchymal transitionrelated markers in extrahepatic cholangiocarcinoma : comprehensive immunohistochemical study using a tissue microarray", Br J Cancer, 111, pp.1363~1372 (2014)
40. Xia W, "Radiogenomics of hepatocellular carcinoma : multiregion analysis-based identification of prognostic imaging biomarkers by integrating gene data-a preliminary study", Phys Med Biol, 63, pp.035044~ (2018)
41. West DL, "CT-based radiomics analysis of hepatocellular carcinoma patients to predict key genomic information", J Clin Oncol (2017)[DOI]
42. Taouli B, "Imagingbased surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma : preliminary results", Eur Radiol, 27, pp.4472~4481 (2017)
43. Bakr S, "Noninvasive radiomics signature based on quantitative analysis of computed tomography images as a surrogate for microvascular invasion in hepatocellular carcinoma: a pilot study", J Med Imaging(Bellingham), 4, pp.041303~ (2017)
44. Chen S, "Texture analysis of baseline multiphasic hepatic computed tomography images for the prognosis of single hepatocellular carcinoma after hepatectomy : a retrospective pilot study", Eur J Radiol, 90, pp.198~204 (2017)
45. Zhou Y, "CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma", Abdom Radiol(NY), 42, pp.1695~1704 (2017)
46. Zhou W, "Malignancy characterization of hepatocellular carcinomas based on texture analysis of contrast-enhanced MR images", J Magn Reson Imaging, 45, pp.1476~1484 (2017)
47. Suh YJ, "Preoperative prediction of the microvascular invasion of hepatocellular carcinoma with diffusion-weighted imaging", Liver Transpl, 18, pp.1171~1178 (2012)
48. Renzulli M, "Can current preoperative imaging be used to detect microvascular invasion of hepatocellular carcinoma?", Radiology, 279, pp.432~442 (2016)
49. Kim AY, "Hepatobiliary MRI as novel selection criteria in liver transplantation for hepatocellular carcinoma", J Hepatol, 68, pp.1144~1152 (2018)
50. 조은석, "MRI Features of Hepatocellular Carcinoma Related to Biologic Behavior", Korean Journal of Radiology, 16(3), pp.449~464 (2015), 대한영상의학회[DOI]
51. Hui TC, "Predicting early recurrence of hepatocellular carcinoma with texture analysis of preoperative magnetic resonance imaging: a radiomics study", RSNA, ~ (2017)
52. Chen J, "The value of texture analysis on perfusion-weighted magnetic resonance imaging for malignancy characterization of hepatocellular carcinoma", RSNA, ~ (2017)
53. Hectors SJ, "Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging", Sci Rep, 7, pp.2452~ (2017)
54. Aherne EA, "Intrahepatic cholangiocarcinoma: can imaging phenotypes predict survival and tumor genetics?", Abdom Radiol (NY) (2018)[DOI]
55. Asayama Y, "Delayed-phase dynamic CT enhancement as a prognostic factor for mass-forming intrahepatic cholangiocarcinoma", Radiology, 238, pp.150~155 (2006)
56. Lee J, "Mass-forming intrahepatic cholangiocarcinoma : diffusion-weighted imaging as a preoperative prognostic marker", Radiology, 281, pp.119~128 (2016)
57. Pandey A, "Volumetric functional MRI as new prognostic marker to predict survival in unresectable intrahepatic cholangiocarcinoma undergoing systemic chemotherapy: long term single institution outcomes", RSNA, ~ (2017)
58. McShane LM, "Reporting recommendations for tumor marker prognostic studies(REMARK)", J Natl Cancer Inst, 97, pp.1180~1184 (2005)

관련 논문AI추천